SkinBioTherapeutics plc (AIM:SBTX)
London · Delayed Price · Currency is GBP · Price in GBX 11.50
-0.75 (-6.12%)
Jul 24, 2026, 3:51 PM GMT
SkinBioTherapeutics Income Statement
Financials in millions GBP. Fiscal year is July - June.
Millions GBP. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 4.46 | 3.87 | 1.21 | 0.13 | 0.07 | - | |
Revenue Growth (YoY) | 15.23% | 220.12% | 815.26% | 76.64% | - | - |
Cost of Revenue | 2.04 | 1.78 | 0.53 | 0.05 | 0.03 | - |
Gross Profit | 2.42 | 2.09 | 0.68 | 0.09 | 0.05 | - |
Selling, General & Admin | 4.34 | 4.09 | 3.03 | 2.15 | 2.17 | 0.99 |
Research & Development | 0.17 | 0.13 | 0.56 | 0.93 | 0.86 | 0.51 |
Total Operating Expenses | 4.52 | 4.22 | 3.59 | 3.08 | 3.03 | 1.5 |
Operating Income | -2.1 | -2.13 | -2.91 | -3 | -2.98 | -1.5 |
Interest Expense | -0.12 | -0.09 | -0.04 | -0.01 | -0.01 | -0 |
Other Non-Operating Income (Expense) | 0.75 | 0.5 | - | - | - | - |
Total Non-Operating Income (Expense) | 0.63 | 0.41 | -0.04 | -0.01 | -0.01 | -0 |
Pretax Income | -1.47 | -1.72 | -2.95 | -3.01 | -2.99 | -1.5 |
Provision for Income Taxes | 0.03 | 0.03 | -0.07 | -0.17 | -0.2 | -0.07 |
Net Income | -1.5 | -1.74 | -2.88 | -2.84 | -2.79 | -1.43 |
Net Income to Common | -1.5 | -1.74 | -2.88 | -2.84 | -2.79 | -1.43 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 246 | 228 | 186 | 165 | 157 | 147 |
Shares Outstanding (Diluted) | 246 | 228 | 186 | 165 | 157 | 147 |
Shares Change (YoY) | 7.85% | 22.32% | 13.10% | 5.06% | 6.87% | 14.53% |
EPS (Basic) | -0.00 | -0.00 | -0.02 | -0.02 | -0.02 | -0.01 |
EPS (Diluted) | -0.00 | -0.00 | -0.02 | -0.02 | -0.02 | -0.01 |
EPS Growth | - | - | - | - | - | - |
Free Cash Flow | -1.97 | -1.24 | -2.74 | -2.73 | -2.67 | -1.56 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -0.01 | -0.01 | -0.01 | -0.02 | -0.02 | -0.01 |
Gross Margin | 54.22% | 54.02% | 56.51% | 64.51% | 60.64% | - |
Operating Margin | -47.06% | -54.94% | -240.36% | -2271.26% | -3988.83% | - |
Profit Margin | -33.72% | -45.05% | -237.95% | -2146.91% | -3735.37% | - |
FCF Margin | -44.18% | -32.08% | -226.80% | -2071.02% | -3575.44% | - |
EBITDA | -1.56 | -1.7 | -2.73 | -2.95 | -2.94 | -1.49 |
EBITDA Margin | -35.00% | -43.92% | -225.80% | -2231.06% | -3935.58% | - |
EBIT | -2.1 | -2.13 | -2.91 | -3 | -2.98 | -1.5 |
EBIT Margin | -47.06% | -54.94% | -240.36% | -2271.26% | -3988.83% | - |
Effective Tax Rate | -2.22% | -1.48% | 2.47% | 5.75% | 6.67% | 4.34% |